Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$1.48 - $2.68 $148 - $268
100 Added 1.62%
6,262 $16,000
Q4 2021

Jan 24, 2022

BUY
$1.27 - $8.28 $254 - $1,655
200 Added 3.35%
6,162 $28,000
Q2 2020

Jul 20, 2020

BUY
$7.14 - $14.41 $42,568 - $85,912
5,962 New
5,962 $43,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $2.15M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.